А. И. Ершова
-
- Cardiovascular Health and Disease Prevention 9
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 10
-
- Lipoproteins and Cardiovascular Health 30
-
- Cancer, Lipids, and Metabolism 9
-
- Healthcare Systems and Public Health 9
-
- Genetic Associations and Epidemiology 16
- Nutrition, Genetics, and Disease 11
- Genomics and Rare Diseases 10
- Co-authors
- А. Н. МешковS. А. BoytsovS. А. ShalnovaО. М. ДрапкинаА. В. КиселеваА. Д. ДеевOxana M. DrapkinaТ. В. Балахонова
- Partner nations
- RussiaTajikistanUnited States
In The Last Decade
А. И. Ершова
75 papers receiving 418 citations
Peers
Comparison fields: 5 of 72
- Cardiology and Cardiovascular Medicine 221
- Endocrinology, Diabetes and Metabolism 93
- Surgery 188
- Cancer Research 58
- Epidemiology 95
Countries citing papers authored by А. И. Ершова
This map shows the geographic impact of А. И. Ершова's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by А. И. Ершова with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites А. И. Ершова more than expected).
Fields of papers citing papers by А. И. Ершова
This network shows the impact of papers produced by А. И. Ершова. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by А. И. Ершова. The network helps show where А. И. Ершова may publish in the future.
Co-authorship network
The 25 scholars most cited alongside А. И. Ершова, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 3 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 0 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 0 | |
| 12 | 2023 | 1 | |
| 13 | 2022 | 1 | |
| 14 | 2022 | 0 | |
| 15 | 2022 | 2 | |
| 16 | 2021 | 1 | |
| 17 | 2021 | 1 | |
| 18 | Cystic Fibrosis Polymorphic Variants in a Russian Population | 2020 | 6 |
| 19 | 2020 | 5 | |
| 20 | 2019 | 15 |
About А. И. Ершова
А. И. Ершова is a scholar working on Cardiology and Cardiovascular Medicine, Genetics and Cancer Research, having authored 98 papers that have together received 487 indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (30 papers), Genetic Associations and Epidemiology (16 papers), Nutrition, Genetics, and Disease (11 papers), Genomics and Rare Diseases (10 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers), Healthcare Systems and Public Health (9 papers), Cancer, Lipids, and Metabolism (9 papers) and Cardiovascular Health and Disease Prevention (9 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (221 citations), Endocrinology, Diabetes and Metabolism (93 citations) and Surgery (188 citations). А. И. Ершова has collaborated with scholars based in Russia, Tajikistan and United States. Frequent co-authors include А. Н. Мешков, S. А. Boytsov, S. А. Shalnova, О. М. Драпкина, А. В. Киселева, А. Д. Деев, Oxana M. Drapkina, Т. В. Балахонова, S. Yu. Martsevich and Anastasia A. Zharikova. Their work appears in journals such as PLoS ONE, Journal of Personalized Medicine, Atherosclerosis, International Journal of Molecular Sciences and Frontiers in Cardiovascular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.